PL3499240T3 - Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera - Google Patents

Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera

Info

Publication number
PL3499240T3
PL3499240T3 PL19153222.5T PL19153222T PL3499240T3 PL 3499240 T3 PL3499240 T3 PL 3499240T3 PL 19153222 T PL19153222 T PL 19153222T PL 3499240 T3 PL3499240 T3 PL 3499240T3
Authority
PL
Poland
Prior art keywords
kynurenine
depression
marker
early detection
vitro method
Prior art date
Application number
PL19153222.5T
Other languages
English (en)
Inventor
Dietmar Abendroth
Manfred J. Stangl
Michael Marzinzig
Original Assignee
Salion Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salion Gmbh filed Critical Salion Gmbh
Publication of PL3499240T3 publication Critical patent/PL3499240T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • G01N2800/245Transplantation related diseases, e.g. graft versus host disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7057(Intracellular) signaling and trafficking pathways
    • G01N2800/7066Metabolic pathways
    • G01N2800/7076Amino acid metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7095Inflammation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
PL19153222.5T 2013-05-03 2014-05-02 Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera PL3499240T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13166375.9A EP2799878A1 (en) 2013-05-03 2013-05-03 In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.

Publications (1)

Publication Number Publication Date
PL3499240T3 true PL3499240T3 (pl) 2024-12-02

Family

ID=48227033

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14721366T PL2992332T3 (pl) 2013-05-03 2014-05-02 Sposób in vitro wczesnego wykrywania potencjalnego zapalenia związanego z odrzucaniem przeszczepu
PL19153222.5T PL3499240T3 (pl) 2013-05-03 2014-05-02 Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL14721366T PL2992332T3 (pl) 2013-05-03 2014-05-02 Sposób in vitro wczesnego wykrywania potencjalnego zapalenia związanego z odrzucaniem przeszczepu

Country Status (12)

Country Link
US (1) US9983212B2 (pl)
EP (3) EP2799878A1 (pl)
JP (2) JP6449247B2 (pl)
KR (1) KR102198869B1 (pl)
CN (1) CN105164537B (pl)
AU (1) AU2014261333B2 (pl)
CA (1) CA2910315C (pl)
DK (1) DK2992332T3 (pl)
ES (2) ES2988827T3 (pl)
PL (2) PL2992332T3 (pl)
PT (1) PT2992332T (pl)
WO (1) WO2014177680A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3070475B1 (en) 2015-03-18 2020-02-19 Karl-Heinz Kellner In vitro diagnostic, prognosis of contrast induced nephropathy
WO2017141966A1 (ja) * 2016-02-15 2017-08-24 学校法人近畿大学 ストレス評価方法
WO2018056431A1 (ja) * 2016-09-26 2018-03-29 池田食研株式会社 L-キヌレニンの測定方法及び測定キット
EP3413050A1 (en) 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
CA3068038A1 (en) * 2017-06-28 2019-01-03 Becton, Dickinson And Company Sandwich-type assays using decreasing signal portions of dose response curve to measure analytes, including analytes at high concentration
WO2019147850A1 (en) * 2018-01-27 2019-08-01 Becton, Dickinson And Company Multiplex lateral flow assay for differentiating bacterial infections from viral infections
WO2019147853A1 (en) * 2018-01-27 2019-08-01 Becton, Dickinson And Company Multiplex lateral flow assay for differentiating bacterial infections from viral infections
KR102699211B1 (ko) * 2018-03-19 2024-08-26 후지필름 가부시키가이샤 정신 질환의 판정 방법
WO2021119487A1 (en) * 2019-12-11 2021-06-17 Magnolia Medical Technologies, Inc. Fluid transfer devices with integrated flow-based assay and methods of using the same
EP4266057A1 (en) 2022-04-20 2023-10-25 SALION GmbH Kynurenine: useful biomarker in acute covid-19 and long covid
WO2024253194A1 (ja) * 2023-06-08 2024-12-12 東洋紡株式会社 脳機能レベルの層別化を支援するための方法、層別化装置、及び層別化プログラム
CN117224519A (zh) * 2023-09-26 2023-12-15 广西大学 L-犬尿氨酸作为一种免疫调节剂在器官移植中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228970A1 (en) * 1995-08-18 1997-02-27 Donald W. Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
US5871905A (en) * 1996-09-04 1999-02-16 Epitope, Inc. Reduction of false positives in oral-fluid based immunoassays
US6102872A (en) * 1997-11-03 2000-08-15 Pacific Biometrics, Inc. Glucose detector and method
GB0400976D0 (en) * 2004-01-16 2004-02-18 Univ Cambridge Tech Methods of diagnosis
ES2261049B1 (es) * 2004-12-16 2007-11-01 Proyecto De Biomedicina Cima, S.L. Dioagnostico de carcinoma hepatocelular mediante la deteccion de formas oxidadas de apolipoproteina a1.
PT2146209E (pt) * 2005-04-06 2011-12-30 Univ Antwerp Marcadores neurodegenerativos para a doença de alzheimer
HUP0700051A2 (en) * 2007-01-17 2008-09-29 Univ Szegedi Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation
US7935494B2 (en) * 2007-03-01 2011-05-03 Carnegie Institution Of Washington Trp/his exchange and kynurenine induced Trp transport
EP2284540A1 (en) * 2009-07-31 2011-02-16 BIOCRATES Life Sciences AG Method of diagnosing organ failure
US8951739B2 (en) * 2009-08-12 2015-02-10 Human Metabolome Technologies Inc. Biomarker for depression, method for measuring a biomarker for depression, computer program, and recording medium
EP2492690A1 (en) * 2011-02-22 2012-08-29 BIOCRATES Life Sciences AG Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants

Also Published As

Publication number Publication date
CN105164537A (zh) 2015-12-16
EP2992332B1 (en) 2019-11-06
KR20160004378A (ko) 2016-01-12
WO2014177680A1 (en) 2014-11-06
AU2014261333B2 (en) 2019-09-12
PT2992332T (pt) 2020-02-19
KR102198869B1 (ko) 2021-01-06
ES2771475T3 (es) 2020-07-06
US20160084843A1 (en) 2016-03-24
PL2992332T3 (pl) 2020-08-10
JP2016520827A (ja) 2016-07-14
AU2014261333A1 (en) 2015-11-19
EP3499240A1 (en) 2019-06-19
ES2988827T3 (es) 2024-11-21
CN105164537B (zh) 2017-12-01
JP2019060880A (ja) 2019-04-18
CA2910315C (en) 2022-05-03
CA2910315A1 (en) 2014-11-06
EP2799878A1 (en) 2014-11-05
US9983212B2 (en) 2018-05-29
EP3499240C0 (en) 2024-07-03
EP3499240B1 (en) 2024-07-03
DK2992332T3 (da) 2020-02-17
JP6449247B2 (ja) 2019-01-09
EP2992332A1 (en) 2016-03-09

Similar Documents

Publication Publication Date Title
PL3499240T3 (pl) Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera
GB2534093B (en) Systems and methods for improved accuracy
SG11201602306SA (en) Methods and system for detecting sequence variants
LU92173B1 (en) Distance determination method
EP2873993A4 (en) INFRARED SHIELDING LAYER
SG11201602976XA (en) Method and system for sensing
HUE056308T2 (hu) Eljárás és rendszer sík félvezetõ tárgyak ellenõrzéséhez
GB201801587D0 (en) Marker Development
PL2950041T3 (pl) Układ i sposób pomiaru odległości
ZA201507727B (en) Road marking
PL3014315T3 (pl) Sposób i układ pomiaru szczelinowalności
IL229860A0 (en) System and method for intrastructural navigation
GB201306627D0 (en) Marker
GB201305207D0 (en) Preamplifier for charged pearticle detection
IL246403A0 (en) Methods and reagents for radioactive labeling
GB2521236B (en) Pool systems and methods for making and using same
EP2973393A4 (en) METHODS AND SYSTEMS FOR STRUCTURAL ANALYSIS
GB201420817D0 (en) Delineating means for a pathway and/or road and a method of use thereof
GB2520633B (en) Marking system
GB2529262B (en) Insignia
GB201314606D0 (en) Insert for reflective road marker
EP3028169A4 (en) Systems and methods for measurement equivalency
GB201308321D0 (en) Top marker
GB201303206D0 (en) Ownership Detection Method
GB201306446D0 (en) Nanopore plasmonic detector